Joyce O'Shaughnessy

Quick facts

Phase 2 pipeline

• Cisplatin & Nab Paclitaxel · Oncology
  Cisplatin is a platinum-based alkylating agent that cross-links DNA, thereby inhibiting DNA replication and transcription. Nab-paclitaxel is a nanoparticle albumin-bound formulation of paclitaxel, which inhibits microtubule dynamics.
• Tak-228 & Tak-117

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Joyce O'Shaughnessy portfolio CI brief
• Joyce O'Shaughnessy pipeline updates RSS